Phillip A. Sharp - Director, Alnylam Pharmaceuticals, Inc

As of July 2, 2019

Phillip A. Sharp Net Worth

• Net worth is estimated to be at least $287.31M
• Owns at least 266,899 units of Alnylam Pharmaceuticals, Inc stock
• Sold an estimated value of $20.25M in the last 15 years at Alnylam Pharmaceuticals, Inc

Phillip A. Sharp Trading

• Largest purchase of shares was 131,890 units , worth over $847.8K on October 15, 2014
• Largest sale of shares was 131,890 units , worth over $9.35M on October 15, 2014
• In total has made about 28 transactions over 15 years
• Usually trades in June, with the busiest year in 2017

Phillip A. Sharp Mailing Address

• Mailing address is Biogen Inc Legal Department 14 Cambridge Center Cambridge MA 02142 MA

Alnylam Pharmaceuticals, Inc Insider Trading

• The most recent transaction was 15,000 units sold on April 5, 2022 by Steven M Paul worth over $2.56M
• In the last 18 years, insiders at Alnylam Pharmaceuticals, Inc sold an estimated value of $488.87M and bought an estimated value of $246.16M
• The most active traders are John Maraganore, Chief Executive Officer,  Akshay Vaishnaw, President,  and Barry E Greene, President
• Insider trading is most common in June, with the busiest year in 2014